WT1 is a protein that is often present on the surface of pleural mesothelioma cells. After clinical trials found that galinpepimut-S (GPS), a WT1-specific vaccine, is safe and effective in causing programmed death in other malignancies where WT1 is present, researchers investigated the impact of combining GPS with nivolumab immunotherapy in previously treated mesothelioma. Preliminary results found that the
Radiation therapy is frequently part of a multi-modality treatment plan for malignant mesothelioma. Radiation therapy is not an invasive procedure, but it does have potential side effects. Knowing how to prepare and how to manage potential side effects will help you through your treatment journey. Understanding Radiation Therapy’s Role in Treating Malignant Mesothelioma Radiation therapy uses high-energy rays
Good nutrition is important for everybody, but especially for patients dealing with the challenges of mesothelioma. While nutrition should not take priority over medical treatments, studies have shown that eating foods rich in certain vitamins can help reduce the side effects of treatments like chemotherapy, improve quality of life, and may even help boost the impact
Researchers across the United Kingdom are recruiting participants for a mesothelioma study being funded by Cancer Research UK. The project, called Meso-ORIGINS, hopes to discover why mesothelioma’s tumors take decades to develop in people who have been exposed to asbestos.
Today, the public is well aware of the dangers of asbestos, but that doesn’t guarantee that they are safe. Many domestic and international agencies have been established with the specific purpose of protecting people from exposure to asbestos and other toxic materials. These regulatory organizations are essential to the safety of workers, as well as others
Mesothelioma is a rare and aggressive form of cancer caused by exposure to asbestos. The disease has proven to be extremely resistant to traditional cancer treatments and is always considered fatal. Though many patients choose aggressive treatment to extend their survival, not all do. Some patients choose a path of palliative care, which helps them manage symptoms and maintain
One of the most challenging aspects of malignant mesothelioma is the significant amount of time that elapses between exposure to asbestos and the disease beginning to make itself known. The disease’s long latency period means that symptoms often don’t arise until fifty or sixty years later, and by the time it is diagnosed, it is
Malignant mesothelioma is a rare and deadly form of cancer caused by exposure to asbestos. The disease can appear in the pleural cavity, the peritoneal cavity, and extremely rarely in the pericardial cavity. Administering heated chemotherapy after tumor removal surgery has proven to be extremely effective in patients with peritoneal mesothelioma, and now researchers say
Weeks after the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) plus pemetrexed and platinum-based chemotherapy for the frontline treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a similar endorsement, signaling its approval of the drug for use
Medical professionals in the United Kingdom are investigating whether mesothelioma patients’ intestinal ecosystem of mesothelioma patients plays a role in their response to immunotherapy. In preliminary investigations, researchers from the University of Leicester sequenced the genetic code of patients’ gut bacteria to determine whether there was a relationship between the two.